Drug
Testosterone
Testosterone: highest development phase Post-Market, developed by Endo, Lupin. 3 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Endo, Lupin
Trials
| Drug | Phase | Indication |
|---|---|---|
| Testosterone Gel NCT01689896 | Post-Market | Low Testosterone |
| TESTOSTERONE | Approved | |
| Testosterone NCT01460654 | Phase 2 | Hypogonadism |
Latest
Follow Testosterone on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.